Capital Access Window

AI SummaryClose X

Sareum Holdings plc announced its intention to undertake an equity capital raise using AIM's new Capital Access Window rule to fund its lead clinical program, SDC-1801. The trading of Sareum's shares on AIM will be temporarily paused from 7:30 am BST today until further announcements detail the results of the proposed fundraise, which aims to advance SDC-1801 towards its next key clinical inflection point.

Disclaimer*

UK 100

Latest directors dealings